Back to Sites

Harare Family Care CRS

Site Number

31890

Address

Cnr Josiah Tongogara/Mazowe Street
Parirenyatwa Annex
Harare,
Zimbabwe

IMPAACT Members at this Site

David Mburuzabudu CAB Member

Audry Tasaranarwo CAB Member

Reginald Maonedzo CAB Representative

Gift Chareka Co-Investigator

Zvenyika Alfred R. Gomo Co-Investigator

Francis Jaji Co-Investigator

Mavis Kahwemba Co-Investigator

Suzen Maonera Co-Investigator

Hilda Mujuru Co-Investigator

Richard Musana Co-Investigator

Mercy Mutambanengwe Co-Investigator

Rachel Mahachi CRS Coordinator

Sukunena Maturure CRS Coordinator

Mutsawashe Bwakura-Dangarembizi CRS Leader

James Hakim CRS Leader

Zvavahera Chirenje CTU Principal Investigator

Bola Adedeji DAIDS PO

Rufaro Katsande Data Manager

Tichaona Vhembo Investigator

Marshall Munjoma Laboratory Manager/Supervisor

Bangani Kusakara Medical Officer

Tapiwa Mbengeranwa Medical Officer

Tsungai Mhembere Pharmacist of Record

Studies at this Site

P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT

DAIDS Number

10166

Research Area

Treatment

Study Status

Concluded

P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects

DAIDS Number

10633

Research Area

Treatment

Study Status

Concluded

P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers

DAIDS Number

10638

Research Area

Complications & Comorbidities

Study Status

Concluded

P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age

DAIDS Number

10655

Research Area

Other

Study Status

Concluded

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

10732

Research Area

Tuberculosis

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Complications & Comorbidities

Study Status

Closed to Follow Up

P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children

DAIDS Number

11689

Research Area

Treatment

Study Status

Participants Off Study and Primary Analysis Completed

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

11773

Research Area

Treatment

Study Status

Closed to Accrual

1077BF: PROMISE 1077BF

DAIDS Number

10777

Research Area

Prevention

Study Status

Participants Off Study and Primary Analysis Completed

P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls

DAIDS Number

11878

Research Area

Complications & Comorbidities

Study Status

Participants Off Study and Primary Analysis Completed